胃间质瘤分子生物学研究进展(4)
[14]Haller F，Moskalev EA，Faucz FR，Barthelme? S，Wiemann S，Bieg M，et al.Aberrant DNA hypermethylation of SDHC：a novel mechanism of tumor development in Carney triad.Endocr Relat Cancer.2014；21：567-77.
[15]Killian JK，Kim SY，Miettinen M，et a1.Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor[J].Cancer Discov，2013，3(6)：648-657.
[16]Urbini M1，Astolfi A2，Indio V3，Heinrich MC4，CorlessCL5，Nannini M6，Ravegnini G7，Biasco G8，9，Pantaleo MA10，11.SDHC methylation in gastrointestinal stromal tumors (GIST)：a case report.BMC Med Genet.2015 Sep 28；16(1)：87.
[17]Yang F C，Ingram D A，ChenS，et al.Neurofibromin-deficient Schwann cells[J].J Clin Invest，2003，112：1851-61.
[18]Pedersen M，R?nnstrand L，Sun J.The C-kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of C-kit[J]. Cell Signal，2009，21(3)：413-418.12.
[19]Vega-Ruiz A，Cortes JE，Sever M， etal.Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis[J]. Leuk Res，2009，33(11)：1481-1484.
本文編辑：李 豆, 百拇医药(宋静 黄留业 张波)
[15]Killian JK，Kim SY，Miettinen M，et a1.Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor[J].Cancer Discov，2013，3(6)：648-657.
[16]Urbini M1，Astolfi A2，Indio V3，Heinrich MC4，CorlessCL5，Nannini M6，Ravegnini G7，Biasco G8，9，Pantaleo MA10，11.SDHC methylation in gastrointestinal stromal tumors (GIST)：a case report.BMC Med Genet.2015 Sep 28；16(1)：87.
[17]Yang F C，Ingram D A，ChenS，et al.Neurofibromin-deficient Schwann cells[J].J Clin Invest，2003，112：1851-61.
[18]Pedersen M，R?nnstrand L，Sun J.The C-kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of C-kit[J]. Cell Signal，2009，21(3)：413-418.12.
[19]Vega-Ruiz A，Cortes JE，Sever M， etal.Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis[J]. Leuk Res，2009，33(11)：1481-1484.
本文編辑：李 豆, 百拇医药(宋静 黄留业 张波)